SCHEMBL7937480

SCHEMBL7937480

COc1cccc(-c2[c]c3ccc(OC)cc3cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.46
CYP2A6 P11509 3/20 0.46
HSD17B1 P14061 1/20 0.45
HSD17B2 P37059 1/20 0.45
GSTP1 P09211 1/20 0.42
DYRK1A Q13627 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
PLAU P00749 2/20 0.42
PLG P00747 1/20 0.42
PLAT P00750 1/20 0.42
CYP11B2 P19099 4/20 0.41
CYP11B1 P15538 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP17A1 P05093 2/20 0.41
CYP19A1 P11511 1/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP1A1 P04798 2/20 0.41
CYP2E1 P05181 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9054823 0.89 CYP1A2 (0.52) CYP1A2CYP2A6HSD17B1HSD17B2GSTP1
SCHEMBL27822793 0.88 DYRK1A (0.39) CYP1A2CYP2A6DYRK1ACLK4NPC1
SCHEMBL27822808 0.88 SMN1; SMN2 (0.41) CYP1A2CYP2A6DYRK1ACLK4NPC1
SCHEMBL8734451 0.88 GAPDH (0.53) PLAUPLGPLATNPC1RAB9A
SCHEMBL8732840 0.88 GAPDH (0.53) PLAUPLGPLATNPC1RAB9A
SCHEMBL27802178 0.88 CYP1A2 (0.46) CYP1A2CYP2A6DYRK1ACLK4PLAU
SCHEMBL7735652 0.85 HSD17B1 (0.49) CYP1A2CYP2A6HSD17B1HSD17B2GSTP1
SCHEMBL11723042 0.85 CYP2A6 (0.52) CYP1A2CYP2A6HSD17B1HSD17B2GSTP1
SCHEMBL8735796 0.81 GAPDH (0.49) NPC1RAB9ACYP3A4TDP1
SCHEMBL8734522 0.80 HSD17B1 (0.41) CYP1A2CYP2A6HSD17B1HSD17B2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0826680-B1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods of preparation thereof. LILLY CO ELI (US) 2001-10-24 EP disclosed
US-5958916-A FOR INHIBITING BONE LOSS OR BONE RESORPTION ELI LILLY AND COMPANY (US) 1999-09-28 US disclosed
EP-0826680-A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods ELI LILLY AND COMPANY (US) 1998-03-04 EP disclosed
EP-0826670-A1 Naphthalene compounds, intermediates, formulations, and methods ELI LILLY AND COMPANY (US) 1998-03-04 EP disclosed